{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:54:31Z","timestamp":1794336871488,"version":"4.9.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25ama121026"],"award-info":[{"award-number":["JP25ama121026"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["JP24H01760"],"award-info":[{"award-number":["JP24H01760"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Drug Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    A key challenge in structure-based drug design is generating three-dimensional molecules while preserving essential protein-ligand interactions. We propose DiffPharma, a structure-based pharmacophore modeling framework based on a conditional diffusion model, to generate molecules that satisfy specified interaction constraints. The proposed method incorporates a semantic fusion architecture that integrates multiple interaction-specific neural networks, each designed to capture distinct molecular interactions such as hydrogen bonds and hydrophobic interactions. Experimental results demonstrate that DiffPharma achieves a residue-level interaction similarity of up to 0.9, significantly outperforming baseline models. To assess the method\u2019s generalizability, ligands were generated for AKT serine\/threonine kinase 1 and serine\n                    <jats:italic>\u03b2<\/jats:italic>\n                    -lactamase, successfully preserving key interaction features. The effectiveness of the method is demonstrated through a practical case study targeting the SARS-CoV-2 main protease. Molecular dynamics simulations indicate that the generated molecules maintain both structural stability and key interactions comparable to those of a bioactive reference ligand. In addition, the molecular mechanics generalized Born surface area (MM\/GBSA) calculations based on MD trajectories suggest that several generated molecules may exhibit relatively favorable binding tendencies compared with the reference. The implementation of the DiffPharma, including code and an execution environment on Google Colab, is available under the MIT license at GitHub:\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/github.com\/sekijima-lab\/DiffPharma\" ext-link-type=\"uri\">https:\/\/github.com\/sekijima-lab\/DiffPharma<\/jats:ext-link>\n                    .\n                  <\/jats:p>","DOI":"10.1038\/s44386-026-00040-x","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T10:48:18Z","timestamp":1772448498000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Interaction-constrained 3D molecular generation using a diffusion model enables structure-based pharmacophore modeling for drug design"],"prefix":"10.1038","volume":"3","author":[{"given":"Masami","family":"Sako","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuaki","family":"Yasuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Sekijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"40_CR1","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/anie.198607673","volume":"25","author":"WG Hol","year":"1986","unstructured":"Hol, W. G. Protein crystallography and computer graphics-toward rational drug design. Angew. Chem. Int. Ed. Engl. 25, 767\u2013778 (1986).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"40_CR2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/326347a0","volume":"326","author":"T Blundell","year":"1987","unstructured":"Blundell, T., Sibanda, B., Sternberg, M. & Thornton, J. Knowledge-based prediction of protein structures and the design of novel molecules. Nature 326, 347\u2013352 (1987).","journal-title":"Nature"},{"key":"40_CR3","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1126\/science.257.5073.1078","volume":"257","author":"ID Kuntz","year":"1992","unstructured":"Kuntz, I. D. Structure-based strategies for drug design and discovery. Science 257, 1078\u20131082 (1992).","journal-title":"Science"},{"key":"40_CR4","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0969-2126(00)00060-5","volume":"2","author":"CL Verlinde","year":"1994","unstructured":"Verlinde, C. L. & Hol, W. G. Structure-based drug design: progress, results and challenges. Structure 2, 577\u2013587 (1994).","journal-title":"Structure"},{"key":"40_CR5","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1021\/jm00090a001","volume":"35","author":"YC Martin","year":"1992","unstructured":"Martin, Y. C. 3d database searching in drug design. J. Med. Chem. 35, 2145\u20132154 (1992).","journal-title":"J. Med. Chem."},{"key":"40_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/BF00141577","volume":"7","author":"YC Martin","year":"1993","unstructured":"Martin, Y. C. et al. A fast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonists. J. Comput. Aided Mol. Des. 7, 83\u2013102 (1993).","journal-title":"J. Comput. Aided Mol. Des."},{"key":"40_CR7","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1021\/ci950273r","volume":"36","author":"D Barnum","year":"1996","unstructured":"Barnum, D., Greene, J., Smellie, A. & Sprague, P. Identification of common functional configurations among molecules. J. Chem. Inf. Comput. Sci. 36, 563\u2013571 (1996).","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"40_CR8","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1021\/ci800064z","volume":"48","author":"C Barillari","year":"2008","unstructured":"Barillari, C., Marcou, G. & Rognan, D. Hot-spots-guided receptor-based pharmacophores (hs-pharm): a knowledge-based approach to identify ligand-anchoring atoms in protein cavities and prioritize structure-based pharmacophores. J. Chem. Inf. Model. 48, 1396\u20131410 (2008).","journal-title":"J. Chem. Inf. Model."},{"key":"40_CR9","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1021\/ci800105p","volume":"48","author":"C Tintori","year":"2008","unstructured":"Tintori, C., Corradi, V., Magnani, M., Manetti, F. & Botta, M. Targets looking for drugs: a multistep computational protocol for the development of structure-based pharmacophores and their applications for hit discovery. J. Chem. Inf. Model. 48, 2166\u20132179 (2008).","journal-title":"J. Chem. Inf. Model."},{"key":"40_CR10","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1021\/acs.jcim.0c00411","volume":"60","author":"PG Francoeur","year":"2020","unstructured":"Francoeur, P. G. et al. Three-dimensional convolutional neural networks and a cross-docked data set for structure-based drug design. J. Chem. Inf. Model. 60, 4200\u20134215 (2020).","journal-title":"J. Chem. Inf. Model."},{"key":"40_CR11","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1021\/jm0510629","volume":"49","author":"J Deng","year":"2006","unstructured":"Deng, J., Sanchez, T., Neamati, N. & Briggs, J. M. Dynamic pharmacophore model optimization: identification of novel hiv-1 integrase inhibitors. J. Med. Chem. 49, 1684\u20131692 (2006).","journal-title":"J. Med. Chem."},{"key":"40_CR12","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1111\/j.1747-0285.2012.01367.x","volume":"79","author":"Y Niu","year":"2012","unstructured":"Niu, Y. et al. The discovery of novel \u03b2-secretase inhibitors: pharmacophore modeling, virtual screening, and docking studies. Chem. Biol. Drug Des. 79, 972\u2013980 (2012).","journal-title":"Chem. Biol. Drug Des."},{"key":"40_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69337-9","volume":"10","author":"R Yoshino","year":"2020","unstructured":"Yoshino, R., Yasuo, N. & Sekijima, M. Identification of key interactions between sars-cov-2 main protease and inhibitor drug candidates. Sci. Rep. 10, 12493 (2020).","journal-title":"Sci. Rep."},{"key":"40_CR14","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1021\/acs.jcim.1c00258","volume":"61","author":"E Glaab","year":"2021","unstructured":"Glaab, E., Manoharan, G. B. & Abankwa, D. Pharmacophore model for sars-cov-2 3clpro small-molecule inhibitors and in vitro experimental validation of computationally screened inhibitors. J. Chem. Inf. Model. 61, 4082\u20134096 (2021).","journal-title":"J. Chem. Inf. Model."},{"key":"40_CR15","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1039\/D0MD00282H","volume":"12","author":"LS Franco","year":"2021","unstructured":"Franco, L. S., Maia, R. C. & Barreiro, E. J. Identification of lassbio-1945 as an inhibitor of sars-cov-2 main protease (m pro) through in silico screening supported by molecular docking and a fragment-based pharmacophore model. RSC Med. Chem. 12, 110\u2013119 (2021).","journal-title":"RSC Med. Chem."},{"key":"40_CR16","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/S1359-6446(02)02483-2","volume":"7","author":"PD Lyne","year":"2002","unstructured":"Lyne, P. D. Structure-based virtual screening: an overview. Drug Discov. today 7, 1047\u20131055 (2002).","journal-title":"Drug Discov. today"},{"key":"40_CR17","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nature03197","volume":"432","author":"BK Shoichet","year":"2004","unstructured":"Shoichet, B. K. Virtual screening of chemical libraries. Nature 432, 862\u2013865 (2004).","journal-title":"Nature"},{"key":"40_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman, H. M. et al. The protein data bank. Nucleic Acids Res. 28, 235\u2013242 (2000).","journal-title":"Nucleic Acids Res."},{"key":"40_CR19","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1021\/jm030580l","volume":"47","author":"R Wang","year":"2004","unstructured":"Wang, R., Fang, X., Lu, Y. & Wang, S. The pdbbind database: collection of binding affinities for protein- ligand complexes with known three-dimensional structures. J. Med. Chem. 47, 2977\u20132980 (2004).","journal-title":"J. Med. Chem."},{"key":"40_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1021\/ci049714+","volume":"45","author":"JJ Irwin","year":"2005","unstructured":"Irwin, J. J. & Shoichet, B. K. Zinc- a free database of commercially available compounds for virtual screening. J. Chem. Inf. Model. 45, 177\u2013182 (2005).","journal-title":"J. Chem. Inf. Model."},{"key":"40_CR21","doi-asserted-by":"publisher","first-page":"D668","DOI":"10.1093\/nar\/gkj067","volume":"34","author":"DS Wishart","year":"2006","unstructured":"Wishart, D. S. et al. Drugbank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 34, D668\u2013D672 (2006).","journal-title":"Nucleic Acids Res."},{"key":"40_CR22","doi-asserted-by":"publisher","first-page":"W623","DOI":"10.1093\/nar\/gkp456","volume":"37","author":"Y Wang","year":"2009","unstructured":"Wang, Y. et al. Pubchem: a public information system for analyzing bioactivities of small molecules. Nucleic Acids Res. 37, W623\u2013W633 (2009).","journal-title":"Nucleic Acids Res."},{"key":"40_CR23","doi-asserted-by":"publisher","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","volume":"40","author":"A Gaulton","year":"2012","unstructured":"Gaulton, A. et al. Chembl: a large-scale bioactivity database for drug discovery. Nucleic Acids Res. 40, D1100\u2013D1107 (2012).","journal-title":"Nucleic Acids Res."},{"key":"40_CR24","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1021\/acs.jcim.2c01253","volume":"63","author":"BI Tingle","year":"2023","unstructured":"Tingle, B. I. et al. Zinc-22- a free multi-billion-scale database of tangible compounds for ligand discovery. J. Chem. Inf. Model. 63, 1166\u20131176 (2023).","journal-title":"J. Chem. Inf. Model."},{"key":"40_CR25","doi-asserted-by":"publisher","first-page":"D1516","DOI":"10.1093\/nar\/gkae1059","volume":"53","author":"S Kim","year":"2025","unstructured":"Kim, S. et al. Pubchem 2025 update. Nucleic Acids Res. 53, D1516\u2013D1525 (2025).","journal-title":"Nucleic Acids Res."},{"key":"40_CR26","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s10822-013-9672-4","volume":"27","author":"PG Polishchuk","year":"2013","unstructured":"Polishchuk, P. G., Madzhidov, T. I. & Varnek, A. Estimation of the size of drug-like chemical space based on gdb-17 data. J. Comput. Aided Mol. Des. 27, 675\u2013679 (2013).","journal-title":"J. Comput. Aided Mol. Des."},{"key":"40_CR27","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with alphafold 3. Nature 630, 493\u2013500 (2024).","journal-title":"Nature"},{"key":"40_CR28","doi-asserted-by":"crossref","unstructured":"Passaro, S. et al. Boltz-2: Towards accurate and efficient binding affinity prediction. BioRxiv (2025).","DOI":"10.1101\/2025.06.14.659707"},{"key":"40_CR29","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1039\/C9ME00039A","volume":"4","author":"DC Elton","year":"2019","unstructured":"Elton, D. C., Boukouvalas, Z., Fuge, M. D. & Chung, P. W. Deep learning for molecular design-a review of the state of the art. Mol. Syst. Des. Eng. 4, 828\u2013849 (2019).","journal-title":"Mol. Syst. Des. Eng."},{"key":"40_CR30","doi-asserted-by":"publisher","first-page":"5343","DOI":"10.1021\/acs.jcim.0c01496","volume":"61","author":"T Sousa","year":"2021","unstructured":"Sousa, T., Correia, J., Pereira, V. & Rocha, M. Generative deep learning for targeted compound design. J. Chem. Inf. Model. 61, 5343\u20135361 (2021).","journal-title":"J. Chem. Inf. Model."},{"key":"40_CR31","first-page":"1","volume":"3","author":"X Zeng","year":"2022","unstructured":"Zeng, X. et al. Deep generative molecular design reshapes drug discovery.Cell Rep. Med. 3, 1\u201313 (2022).","journal-title":"Cell Rep. Med."},{"key":"40_CR32","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1039\/D1SC05976A","volume":"13","author":"M Ragoza","year":"2022","unstructured":"Ragoza, M., Masuda, T. & Koes, D. R. Generating 3d molecules conditional on receptor binding sites with deep generative models. Chem. Sci. 13, 2701\u20132713 (2022).","journal-title":"Chem. Sci."},{"key":"40_CR33","unstructured":"Peng, X. et al. Pocket2mol: Efficient molecular sampling based on 3d protein pockets. In International Conference on Machine Learning, 17644\u201317655 (PMLR, 2022)."},{"key":"40_CR34","unstructured":"ZHANG, Z., Min, Y., Zheng, S. & Liu, Q. Molecule generation for target protein binding with structural motifs. In The Eleventh International Conference on Learning Representations https:\/\/openreview.net\/forum?id=Rq13idF0F73 (2023)."},{"key":"40_CR35","doi-asserted-by":"publisher","first-page":"13664","DOI":"10.1039\/D1SC04444C","volume":"12","author":"Y Li","year":"2021","unstructured":"Li, Y., Pei, J. & Lai, L. Structure-based de novo drug design using 3d deep generative models. Chem. Sci. 12, 13664\u201313675 (2021).","journal-title":"Chem. Sci."},{"key":"40_CR36","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/s43588-024-00737-x","volume":"4","author":"A Schneuing","year":"2024","unstructured":"Schneuing, A. et al. Structure-based drug design with equivariant diffusion models. Nat. Comput. Sci. 4, 899\u2013909 (2024).","journal-title":"Nat. Comput. Sci."},{"key":"40_CR37","unstructured":"Guan, J. et al. 3d equivariant diffusion for target-aware molecule generation and affinity prediction. In The Eleventh International Conference on Learning Representations https:\/\/openreview.net\/forum?id=kJqXEPXMsE0 (2023)."},{"key":"40_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46569-1","volume":"15","author":"L Huang","year":"2024","unstructured":"Huang, L. et al. A dual diffusion model enables 3d molecule generation and lead optimization based on target pockets. Nat. Commun. 15, 2657 (2024).","journal-title":"Nat. Commun."},{"key":"40_CR39","unstructured":"Qu, Y. et al. Molcraft: structure-based drug design in continuous parameter space. arXiv preprint arXiv:2404.12141 (2024)."},{"key":"40_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47011-2","volume":"15","author":"W Zhung","year":"2024","unstructured":"Zhung, W., Kim, H. & Kim, W. Y. 3d molecular generative framework for interaction-guided drug design. Nat. Commun. 15, 2688 (2024).","journal-title":"Nat. Commun."},{"key":"40_CR41","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1021\/acs.jcim.4c01385","volume":"65","author":"M Sako","year":"2024","unstructured":"Sako, M., Yasuo, N. & Sekijima, M. Diffint: a diffusion model for structure-based drug design with explicit hydrogen bond interaction guidance. J. Chem. Inf. Model. 65, 71\u201382 (2024).","journal-title":"J. Chem. Inf. Model."},{"key":"40_CR42","unstructured":"Ho, J., Jain, A. & Abbeel, P. Denoising diffusion probabilistic models. Adv. Neural Inform. Process. Syst. 33, 6840\u20136851 (2020)."},{"key":"40_CR43","unstructured":"Hoogeboom, E., Satorras, V. G., Vignac, C. & Welling, M. Equivariant diffusion for molecule generation in 3d. In International Conference on Machine Learning, 8867\u20138887 (PMLR, 2022)."},{"key":"40_CR44","doi-asserted-by":"publisher","first-page":"588","DOI":"10.5195\/jmla.2018.515","volume":"106","author":"SW Gabrielson","year":"2018","unstructured":"Gabrielson, S. W. Scifinder. J. Med. Libr. Assoc. 106, 588 (2018).","journal-title":"J. Med. Libr. Assoc."},{"key":"40_CR45","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nchem.1243","volume":"4","author":"GR Bickerton","year":"2012","unstructured":"Bickerton, G. R., Paolini, G. V., Besnard, J., Muresan, S. & Hopkins, A. L. Quantifying the chemical beauty of drugs. Nat. Chem. 4, 90\u201398 (2012).","journal-title":"Nat. Chem."},{"key":"40_CR46","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","volume":"582","author":"Z Jin","year":"2020","unstructured":"Jin, Z. et al. Structure of mpro from sars-cov-2 and discovery of its inhibitors. Nature 582, 289\u2013293 (2020).","journal-title":"Nature"},{"key":"40_CR47","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1126\/science.abl4784","volume":"374","author":"DR Owen","year":"2021","unstructured":"Owen, D. R. et al. An oral sars-cov-2 mpro inhibitor clinical candidate for the treatment of covid-19. Science 374, 1586\u20131593 (2021).","journal-title":"Science"},{"key":"40_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-20900-6","volume":"12","author":"S-i Hattori","year":"2021","unstructured":"Hattori, S. -i et al. A small molecule compound with an indole moiety inhibits the main protease of sars-cov-2 and blocks virus replication. Nat. Commun. 12, 668 (2021).","journal-title":"Nat. Commun."},{"key":"40_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29915-z","volume":"13","author":"DW Kneller","year":"2022","unstructured":"Kneller, D. W. et al. Covalent narlaprevir-and boceprevir-derived hybrid inhibitors of sars-cov-2 main protease. Nat. Commun. 13, 2268 (2022).","journal-title":"Nat. Commun."},{"key":"40_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21060-3","volume":"12","author":"J Osipiuk","year":"2021","unstructured":"Osipiuk, J. et al. Structure of papain-like protease from sars-cov-2 and its complexes with non-covalent inhibitors. Nat. Commun. 12, 743 (2021).","journal-title":"Nat. Commun."},{"key":"40_CR51","doi-asserted-by":"publisher","first-page":"7561","DOI":"10.1021\/acs.jmedchem.2c00303","volume":"65","author":"H Tan","year":"2022","unstructured":"Tan, H., Hu, Y., Jadhav, P., Tan, B. & Wang, J. Progress and challenges in targeting the sars-cov-2 papain-like protease. J. Med. Chem. 65, 7561\u20137580 (2022).","journal-title":"J. Med. Chem."},{"key":"40_CR52","doi-asserted-by":"publisher","first-page":"eabo7201","DOI":"10.1126\/science.abo7201","volume":"382","author":"ML Boby","year":"2023","unstructured":"Boby, M. L. et al. Open science discovery of potent noncovalent sars-cov-2 main protease inhibitors. Science 382, eabo7201 (2023).","journal-title":"Science"},{"key":"40_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-06306-4","volume":"12","author":"GG Rossetti","year":"2022","unstructured":"Rossetti, G. G. et al. Non-covalent sars-cov-2 mpro inhibitors developed from in silico screen hits. Sci. Rep. 12, 2505 (2022).","journal-title":"Sci. Rep."},{"key":"40_CR54","doi-asserted-by":"publisher","first-page":"5815","DOI":"10.1021\/acs.jcim.0c00575","volume":"60","author":"D Su\u00e1rez","year":"2020","unstructured":"Su\u00e1rez, D. & D\u00edaz, N. Sars-cov-2 main protease: a molecular dynamics study. J. Chem. Inf. Model. 60, 5815\u20135831 (2020).","journal-title":"J. Chem. Inf. Model."},{"key":"40_CR55","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.3390\/biom13091339","volume":"13","author":"A Citarella","year":"2023","unstructured":"Citarella, A. et al. Recent advances in sars-cov-2 main protease inhibitors: from nirmatrelvir to future perspectives. Biomolecules 13, 1339 (2023).","journal-title":"Biomolecules"},{"key":"40_CR56","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1021\/acs.jcim.2c01504","volume":"63","author":"J Ding","year":"2023","unstructured":"Ding, J. et al. Vina-gpu 2.0: further accelerating autodock vina and its derivatives with graphics processing units. J. Chem. Inf. Model. 63, 1982\u20131998 (2023).","journal-title":"J. Chem. Inf. Model."},{"key":"40_CR57","doi-asserted-by":"crossref","unstructured":"Bowers, K. J. et al. Scalable algorithms for molecular dynamics simulations on commodity clusters. In Proceedings of the 2006 ACM\/IEEE Conference on Supercomputing, 84\u2013es (2006).","DOI":"10.1145\/1188455.1188544"},{"key":"40_CR58","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/prot.10613","volume":"55","author":"MP Jacobson","year":"2004","unstructured":"Jacobson, M. P. et al. A hierarchical approach to all-atom protein loop prediction. Proteins Struct. Funct. Bioinforma. 55, 351\u2013367 (2004).","journal-title":"Proteins Struct. Funct. Bioinforma."},{"key":"40_CR59","doi-asserted-by":"publisher","first-page":"14047","DOI":"10.1039\/C4CP01378F","volume":"16","author":"F Adasme-Carre\u00f1o","year":"2014","unstructured":"Adasme-Carre\u00f1o, F., Mu\u00f1oz-Gutierrez, C., Caballero, J. & Alzate-Morales, J. H. Performance of the mm\/gbsa scoring using a binding site hydrogen bond network-based frame selection: the protein kinase case. Phys. Chem. Chem. Phys. 16, 14047\u201314058 (2014).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"40_CR60","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2174\/1568026616666161117112604","volume":"17","author":"X Zhang","year":"2017","unstructured":"Zhang, X., Perez-Sanchez, H. & C. Lightstone, F. A comprehensive docking and mm\/gbsa rescoring study of ligand recognition upon binding antithrombin. Curr. Top. Med. Chem. 17, 1631\u20131639 (2017).","journal-title":"Curr. Top. Med. Chem."},{"key":"40_CR61","doi-asserted-by":"publisher","first-page":"W422","DOI":"10.1093\/nar\/gkae236","volume":"52","author":"L Fu","year":"2024","unstructured":"Fu, L. et al. Admetlab 3.0: an updated comprehensive online admet prediction platform enhanced with broader coverage, improved performance, api functionality and decision support. Nucleic Acids Res. 52, W422\u2013W431 (2024).","journal-title":"Nucleic Acids Res."},{"key":"40_CR62","first-page":"21696","volume":"34","author":"D Kingma","year":"2021","unstructured":"Kingma, D., Salimans, T., Poole, B. & Ho, J. Variational diffusion models. Adv. Neural Inf. Process. Syst. 34, 21696\u201321707 (2021).","journal-title":"Adv. Neural Inf. Process. Syst."},{"key":"40_CR63","first-page":"6229","volume":"34","author":"S Luo","year":"2021","unstructured":"Luo, S., Guan, J., Ma, J. & Peng, J. A 3d generative model for structure-based drug design. Adv. Neural Inf. Process. Syst. 34, 6229\u20136239 (2021).","journal-title":"Adv. Neural Inf. Process. Syst."},{"key":"40_CR64","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1038\/nbt.3988","volume":"35","author":"M Steinegger","year":"2017","unstructured":"Steinegger, M. & S\u00f6ding, J. Mmseqs2 enables sensitive protein sequence searching for the analysis of massive data sets. Nat. Biotechnol. 35, 1026\u20131028 (2017).","journal-title":"Nat. Biotechnol."},{"key":"40_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13321-015-0078-2","volume":"7","author":"M W\u00f3jcikowski","year":"2015","unstructured":"W\u00f3jcikowski, M., Zielenkiewicz, P. & Siedlecki, P. Open drug discovery toolkit (oddt): a new open-source player in the drug discovery field. J. Cheminform. 7, 1\u20136 (2015).","journal-title":"J. Cheminform."},{"key":"40_CR66","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1021\/ci049885e","volume":"45","author":"G Wolber","year":"2005","unstructured":"Wolber, G. & Langer, T. Ligandscout: 3-d pharmacophores derived from protein-bound ligands and their use as virtual screening filters. J. Chem. Inf. Model. 45, 160\u2013169 (2005).","journal-title":"J. Chem. Inf. Model."},{"key":"40_CR67","unstructured":"DeLano, W. L. The pymol molecular graphics system (2002). Version 3.0.0."},{"key":"40_CR68","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1109\/MCSE.2007.55","volume":"9","author":"JD Hunter","year":"2007","unstructured":"Hunter, J. D. Matplotlib: a 2d graphics environment. Comput. Sci. Eng. 9, 90\u201395 (2007).","journal-title":"Comput. Sci. Eng."},{"key":"40_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13321-015-0069-3","volume":"7","author":"D Bajusz","year":"2015","unstructured":"Bajusz, D., R\u00e1cz, A. & H\u00e9berger, K. Why is tanimoto index an appropriate choice for fingerprint-based similarity calculations?. J. Cheminform. 7, 1\u201313 (2015).","journal-title":"J. Cheminform."},{"key":"40_CR70","unstructured":"Rdkit: Open-source cheminformatics. http:\/\/www.rdkit.org (2006)."},{"key":"40_CR71","unstructured":"Revvity Signals Software, I. Chemdraw professional (2025). https:\/\/www.revvity.com. Software for chemical structure drawing and analysis. (2025)."},{"key":"40_CR72","unstructured":"Schr\u00f6dinger, L.L.C. Schr\u00f6dinger release 2025-4: Maestro. https:\/\/www.schrodinger.com\/citations\/ (2025)."}],"container-title":["npj Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44386-026-00040-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44386-026-00040-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44386-026-00040-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T12:15:02Z","timestamp":1772453702000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44386-026-00040-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["40"],"URL":"https:\/\/doi.org\/10.1038\/s44386-026-00040-x","relation":{},"ISSN":["3005-1452"],"issn-type":[{"value":"3005-1452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"12 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}